Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P39060 (
endostatin
)
2,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Collagen XVIII is a component of the highly specialized extracellular matrix associated with basement membranes of epithelia and endothelia. In the normal kidney,
collagen XVIII
is distributed throughout glomerular and tubular basement membranes, mesangial matrix, and Bowman's capsule. Proteolytic cleavage within its C-terminal domain releases the fragment
endostatin
, which has antiangiogenic properties. Because damage to the glomerular basement membrane (GBM) accompanies immune-mediated renal injury, we investigated the role of
collagen XVIII
/
endostatin
in this disorder. We induced anti-GBM
glomerulonephritis
in
collagen XVIII
alpha1-null and wild-type mice and compared the resulting matrix accumulation, inflammation, and capillary rarefaction. Anti-GBM disease upregulated
collagen XVIII
/
endostatin
expression within the GBM and Bowman's capsule of wild-type mice. Collagen XVIII/
endostatin
-deficient mice developed more severe glomerular and tubulointerstitial injury than wild-type mice. Collagen XVIII/
endostatin
deficiency altered matrix remodeling, enhanced the inflammatory response, and promoted capillary rarefaction and vascular endothelial cell damage, but did not affect endothelial proliferation. Supplementing
collagen XVIII
-deficient mice with exogenous
endostatin
did not affect the progression of anti-GBM disease. Taken together, these results suggest that
collagen XVIII
/
endostatin
preserves the integrity of the extracellular matrix and capillaries in the kidney, protecting against progressive
glomerulonephritis
.
...
PMID:Lack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis. 2061 67
Collagen XVIII is a heparan sulphate proteoglycan which is expressed ubiquitously in different basement membranes throughout the body. Its C-terminal fragment,
endostatin
, has been found to inhibit angiogenesis and tumor growth by restricting endothelial proliferation and migration and inducing apoptosis of endothelial cells. Collagen XVIII has three variants, of which the shortest one is found in most vascular and epithelial BM structures, whereas the longer variants are found especially in the liver. The longest or frizzled variant has a cysteine-rich domain in its N-terminus that has been shown to inhibit Wnt signaling in vitro. The presence of
collagen XVIII
homologues in organisms such as C. elegans, Xenopus laevis, zebrafish and chick suggests a fundamental role for this BM collagen. Mutations in the
collagen XVIII
gene lead to the Knobloch syndrome, which is characterized by high myopia, vitreoretinal degeneration with retinal detachment, macular abnormalities and occipital encephalocele. Mice lacking
collagen XVIII
also show several ocular abnormalities. This suggests that in physiological conditions
collagen XVIII
is mostly needed for the proper development of the eye. Moreover, it appears to be needed for the structural stability of basement membranes in several other organs, and increasing evidence shows its importance for other organs in non-physiological situations such as atherosclerosis,
glomerulonephritis
or other type of tissue damage. This review focuses on clarifying the roles of
collagen XVIII
and its variants and domains in various physiological and pathological conditions.
...
PMID:The multiple functions of collagen XVIII in development and disease. 2116 48
Endostatin, the C-terminal fragment of
type XVIII collagen
, was shown to be one of the most potent endothelial cell-specific inhibitors of angiogenesis. As altered circulating
endostatin
concentration is associated with impaired kidney function, new tools for measuring
endostatin
in rodents may be helpful to further investigate and understand its role within kidney disease progression. A novel and commercially available ELISA for the quantification of mouse and rat
endostatin
was developed and validated according to international quality guidelines including the parameters specificity, robustness, accuracy, dilution linearity, precision, limit of detection (LOD) and lower limit of quantification (LLOQ). Endostatin and blood urea nitrogen (BUN) concentration were measured in mice with a
glomerulonephritis
phenotype. The validation revealed that within the range of 0.5-32 nmol/L the immunoassay is robust and highly specific for the measurement of rodent
endostatin
with high sensitivity (LOD 0.24 nmol/L, LLOQ 0.5 nmol/L) and good reproducibility (intra- and inter-assay CV <10%). Also accuracy and dilution linearity were within the range of acceptance. BCL2 transgenic and ETV6/RUNX1;BCL2 double transgenic mice develop a
glomerulonephritis
phenotype over time, which was displayed by staining of kidney sections. Even before full manifestation of disease serum
endostatin
concentration rises significantly, whereas BUN levels just slightly increase. This newly developed and commercially available ELISA provides a reliable and accurate tool for the quantification of mouse and rat
endostatin
and may give new perspectives in the investigation of the role of
endostatin
as an important and early biomarker for reduced kidney function. Measurement of
endostatin
concentration is recommended to be used as a superior biomarker for chronic kidney disease compared to BUN.
...
PMID:Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritis. 3140 20